Vapourtec Expands R-Series Capabilities
News Nov 19, 2014
The R2-S pump module is a special self priming, suspension / slurry capable version that is ideal for organometallic reagents, metering gases and strong acids such as fuming Nitric Acid and can be added to an existing two pump arrangement to deliver enhanced capability.
Vapourtec MD Duncan Guthrie commented: "At the heart of the R2-S is our V-3 precision peristaltic pump which features advanced control and is capable of handling strong acids, bases and organometallic reagents as well as a range of gases and generates a smooth output flow across the full pressure range.
"Nearly 200 of the V-3 pumps are in daily use in labs around the world and its capability to pump organometallic reagents has been well documented in peer reviewed publications.
"We launched the R-Series in 2007 and it has since gone on to become one of the world's leading flow chemistry systems. The addition of the R2-S pump module significantly increases the potential of the R-Series," added Duncan.
Vapourtec design and manufacture flow chemistry systems for a wide variety of sectors across the globe including education, pharmaceutical and industry and their technology has been cited in over 125 published papers as playing a pivotal part in recent major research breakthroughs.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Shaken and Stirred: Scaling Up Bioreactors’ Fluid DynamicsNews
By applying analytical techniques often reserved for large-scale industrial bioreactors to smaller lab-based counterparts, researchers are bridging the gap between different ways of mixing biomaterials.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE